Dr. Schirger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
700 West Ave S
La Crosse, WI 54601Phone+1 608-785-0940Fax+1 507-255-3125
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Cardiovascular Disease, 2002 - 2008
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1999 - 2002
- Creighton University School of MedicineClass of 1999
Certifications & Licensure
- MN State Medical License 2000 - 2025
- WI State Medical License 2014 - 2025
- OH State Medical License 2020 - 2024
- AZ State Medical License 2017 - 2022
- FL State Medical License 2017 - 2019
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Clinical Trials
- Effects of Chimeric Natriuretic Peptide Versus Placebo in Stable Heart Failure and Moderate Renal Dysfunction Start of enrollment: 2014 Jan 01
- Safety Study of Chimeric Natriuretic Peptide(CD-NP) in Stable LVAD Patients Start of enrollment: 2013 Apr 01
- CD-NP (Cenderitide) Therapy for the Preservation of Left Ventricular Function Start of enrollment: 2013 Oct 01
Publications & Presentations
PubMed
- A Case of Acute Decompensated Heart Failure Complicated by Cardiorenal Syndrome Treated With Ultrafiltration.Gaurav Mandal, Tarig Elraiyah, Charn Nandra, Rick Greco, John Schirger
Cureus. 2022-09-01 - 3 citationsRoutine Laboratory Biomarkers As Prognostic Indicators of Cardiac Sarcoidosis Outcomes.Nikhil Kolluri, Tyler J Schmidt, Mohamed Y Elwazir, Suraj Kapa, Omar F Abou Ezzeddine
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases. 2022-01-01 - 20 citationsElectrogram-guided endomyocardial biopsy yield in patients with suspected cardiac sarcoidosis and relation to outcomes.Fatima M. Ezzeddine, Suraj Kapa, Andrew N. Rosenbaum, Lori A. Blauwet, Abhishek Deshmukh
Journal of Cardiovascular Electrophysiology. 2021-08-09
Authored Content
- Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
- Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
- Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
- Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
- Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
- Join now to see all
Press Mentions
- Trinity Health System Expands Structural Heart ProgramSeptember 7th, 2022
- Trinity Health System in Steubenville Launches New Heart Valve ProcedureMay 15th, 2021
- Catholic Medical Association Issues Support of the Palliative Care and Hospice Education and Training ActSeptember 23rd, 2019
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: